Peter Maccallum Cancer Centre
Peter Maccallum Cancer Centre
Parkville, Victoria, Australia2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2026-09-23 | NCT06619587 | |
| A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, PIK3CA-related overgrowth spectrum, Skin and Connective Tissue Diseases, arteriovenous hemangioma/malformation, cardiovascular disorder, cystic hygroma, lymphangioma, lymphatic malformation, lymphatic system disorder, neoplasm, skin disorder, skin vascular disease, vascular disorder, vascular malformation, venous hemangioma | Recruiting | Phase 2 | 2026-05-05 | NCT05983159 |